South Street Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
South Street Advisors's HALO Position: Q2 2026 in Review
South Street Advisors increased its Halozyme (HALO) stake by 2.5% in Q2 2026, buying an estimated $392K and bringing the position to 238,689 shares worth $18.7M. The position accounts for 2.43% of the portfolio, ranked #20.
South Street Advisors first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- South Street Advisors held 238,689 shares of Halozyme worth $18.7M as of Q2 2026.
- South Street Advisors bought 5,749 Halozyme shares in Q2 2026, an estimated $392K.
- Halozyme made up 2.43% of South Street Advisors's portfolio in Q2 2026, its #20 holding.
- South Street Advisors first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on South Street Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.